Retrospective study of the impact of KPC and NDM genes on multidrug-resistant infections: in a reference hospital in Piauí, Brazil.
DOI:
https://doi.org/10.17058/reci.v15i4.19939Keywords:
Antibiotic resistance, Resistance genes, Klebsiella pneumoniae, Outcome Assessment, Health CareAbstract
Background and Objectives: Klebsiella pneumoniae carbapenemase (KPC) and New Delhi metallo-beta-lactamase (NDM) carbapenemases confer resistance to last-line antibiotics, compromising treatment and worsening clinical outcomes. This retrospective and descriptive study aimed to analyze the frequency of multidrug-resistant bacteria in cultures from patients admitted to a reference hospital in Piauí, Brazil, and their correlation with patient outcomes, including affected hospital sectors, clinical progression, and length of stay. Methods: Conducted in a reference tertiary hospital and through data analysis covering the period from January 2021 to December 2022, it highlights the prevalence and resistance mechanisms of bacterial species, with an emphasis on the KPC and NDM genes. Results: KPC was predominantly found in Pseudomonas aeruginosa and K. pneumoniae, whereas NDM was mainly detected in K.pneumoniae and Serratia marcescens. Some species, particularly K. pneumoniae, exhibited dual resistance genes. The study revealed higher mortality rates when both KPC and NDM genes were present: 45.83% for KPC, 43.75% for NDM, and 65.71% for infections with both genes. It also explored hospital stay lengths, showing KPC infections averaged 58.9 days, NDM infections 69 days, and dual gene infections 49 days. Conclusion: This research provides critical insights into the challenges of antibiotic-resistant organisms in hospitals, underscoring the need for effective patient management and resource allocation strategies. To the best of our knowledge, this study uncovers the first documented cases of NDM gene infections in Piauí.
Downloads
References
1. Rodríguez-Villodres A, Martín-Gandul C, Peñalva G, et al. Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review. Antibiotics (Basel). 2021;10(6):680. Available from: https://doi.org/10.3390/antibiotics10060680
2. Kapadia SN, Abramson EL, Carter EJ, et al. The expanding role of antimicrobial stewardship programs in hospitals in the United States: lessons learned from a multisite qualitative study. Jt Comm J Qual Patient Saf. 2018;44(2):68–74. Available from: https://doi.org/10.1016/j.jcjq.2017.07.007
3. Padiyara P, Inoue H, Sprenger M. Global governance mechanisms to address antimicrobial resistance. Infect Dis (Auckl). 2018;11:1–8. Available from: https://doi.org/10.1177/1178633718767887
4. Chan JFW, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23. Available from: https://doi.org/10.1016/S0140-6736(20)30154-9
5. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–9. Available from: https://doi.org/10.1038/s41586-020-2202-3
6. Van Laethem J, Wuyts S, Van Laere S, et al. Antibiotic prescriptions targeting bacterial respiratory infections in admitted patients with Covid-19: a prospective observational study. Infect Dis Ther. 2021. Available from:https://doi.org/10.1007/s40121-021-00535-2
7. Ukuhor HO. The interrelationships between antimicrobial resistance, Covid-19, past, and future pandemics. J Infect Public Health. 2021;14(1):53–60. Available from: https://doi.org/10.1016/j.jiph.2020.10.018
8. Da Silva IR, Aires CAM, Conceição-Neto OC, et al. Distribution of clinical NDM-1-producing gram-negative bacteria in Brazil. Microb Drug Resist. 2019;25(3):394–9. Available from:https://doi.org/10.1089/mdr.2018.0240
9. Kritsotakis EI, Kontopidou F, Astrinaki E, et al. Prevalence, incidence burden and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece. Infect Drug Resist. 2017;10:317–28. Available from: https://doi.org/10.2147/IDR.S147459
10. Rosenthal VD, Rodríguez-Calderón ME, Rodríguez-Ferrer M, et al. Findings of the International Nosocomial Infection Control Consortium (INICC), part II: impact of a multidimensional strategy to reduce ventilator-associated pneumonia in neonatal intensive care units in 10 developing countries. Infect Control Hosp Epidemiol. 2012;33(7):704–10. Available from: https://doi.org/10.1086/666342
11. Zimlichman E, Henderson D, Tamir O, et al. Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–46. Available from: https://doi.org/10.1001/jamainternmed.2013.9763
12. Röder DV, de Almeida Santos J, Eire Urzedo J, et al. Surtos bacterianos em uma unidade de terapia intensiva neonatal: histórico de cinco anos. Arq Ciênc Saúde. 2019;26(2):136. Available from: https://doi.org/10.17696/2318-3691.26.2.2019.1431
13. BRCAST. Documentos. Available from: https://brcast.org.br/documentos/
14. MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med. 2017;32(1):25–37. Available from: doi:https://doi.org/10.1177/0885066615619895
15. Gajdács M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics (Basel). 2019;8(3):129. Available from: https://doi.org/10.3390/antibiotics8030129
16. Baughman RP. The use of carbapenems in the treatment of serious infections. J Intensive Care Med. 2009;24(4):230–41. Available from: https://doi.org/10.1177/0885066609335660
17. Tian X, Zheng X, Sun Y, et al. Molecular mechanisms and epidemiology of carbapenem-resistant Escherichia coli isolated from Chinese patients during 2002–2017. Infect Drug Resist. 2020;13:501–12. Available from: https://doi.org/10.2147/IDR.S232010
18. Bassetti M, Peghin M, Vena A, et al. Treatment of infections due to MDR gram-negative bacteria. Front Med. 2019;6. Available from: https://doi.org/10.3389/fmed.2019.00074
19. Hendrik TC, Voor in ’t Holt AF, Vos MC. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella spp.: a systematic review and meta-analyses. PLoS One. 2015;10(10). Available from: https://doi.org/10.1371/journal.pone.0140754
20. Talaat M, Hafez S, Saied T, et al. Surveillance of catheter-associated urinary tract infection in 4 intensive care units at Alexandria University hospitals in Egypt. Am J Infect Control. 2010;38(3):222–8. Available from: https://doi.org/10.1016/j.ajic.2009.06.011
21. Araújo FHA, Fernandes LHS. Lighting the populational impact of Covid-19 vaccines in Brazil. Fractals. 2022. Available from: https://doi.org/10.1142/S0218348X22500669
22. Watson OJ, et al. Global impact of the first year of Covid-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022. Available from: https://doi.org/10.1016/S1473-3099(22)00320-6
23. Orellana JD, Cunha GM, Marrero L, et al. Mudanças no padrão de internações e óbitos por Covid-19 após substancial vacinação de idosos em Manaus, Amazonas, Brasil. Cad Saúde Pública. 2022;38(5). Available from: https://doi.org/10.1590/0102-311XPT192321
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ruana Stephany Macedo Santos, Eduardo Lima de Sousa, Thallyta Maria Tavares Antunes, Samara Belchior Gaído, José Felipe Pinheiro do Nascimento Vieira, Bruno Guedes Alcoforado Aguiar

This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.